BIT's 10th World Congress of Vaccine-2017, Singapore
★ Tentative Program

 

Program

Time: November 15-17, 2017

Venue: Furama RiverFront, Singapore


Registration

Time: 09:00-21:00, November 14, 2017 (Tuesday); Place: Furama RiverFront, Singapore

 

Opening Ceremony and Keynote Forum

Opening Ceremony and Keynote Forum

Time: 09:00-11:00, November 15, 2017 (Wednesday); Place: Venus I, Level 3

 

Moderator

Dr. James (Jianguo) Yang, CEO/President, China Division, Abpro, China

 

09:00-09:30

Title: Creative Capacity: Innovative Solutions for the Future of Bioproduction
Dr. Daria Donati, Director, Healthcare Life Sciences, Sweden

09:30-10:00

Title: Ethical Issues in Vaccines Clinical Trial
Dr. Teoh Yee Leong, CEO, Singapore Clinical Research Institute, Singapore

10:00-10:30

Title: Immunotherapy with PreS-based Grass Pollen Allergy Vaccine BM32 induces Antibody Responses Protecting against Hepatitis B Infection
Dr. Rainer Henning, CEO, Viravaxx GmbH, Austria

10:30-11:00

Title: Neonatal and Early Immunization Strategies: The Future for Global Rotavirus Vaccination
Dr. Michel Klein, Chief Strategy Officer, BravoVax Co., Ltd., China

 

Track 1: Latest Research and Technologies in Vaccines Development

Track 1-1: Latest Research and Technologies in Vaccines Development (I)

Time: 14:00-17:10, November 15, 2017 (Wednesday); Place: Venus I, Level 3

 

Chair

Dr. Michel Klein, Chief Strategy Officer, BravoVax Co., Ltd., China

Co-Chair

Dr. Frank-Holm Roegner, Head of Department Electron Beam Processes, Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, Germany

 

14:00-14:25

Title: Neonatal and Early Immunization Strategies: The Future for Global Rotavirus Vaccination
Dr. Michel Klein, Chief Strategy Officer, BravoVax Co., Ltd., China

14:25-14:50

Title: A New One-component Universal Pneumococcal Vaccine for Prevention of Pneumococcal Infections
Dr. Dong-Sheng (Don) Chen, President/CEO, Rockville Innovation Center, USA

14:50-15:15

Title: Genetic and Somatic Constraints on Antigen Receptor Diversity Influence Patterns of Epitope Recognition
Dr. Harry W. Schroeder, Professor, University of Alabama at Birmingham, USA

15:15-15:30

Coffee Break

15:30-15:55

Title: Complications after BCG Vaccination in Patients with Severe Combined Immunodeficiency
Dr. Gerard Pasternak, Assistant Professor, Wroclaw Medical University, Poland

15:55-16:20

Title: Energy Electron Beam Inactivation for innovative Vaccine Production
Dr. Frank-Holm Roegner, Head of Department Electron Beam Processes, Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, Germany

16:20-16:45

Title: Chemically Modified Allergens - Allergoids in Specific Immunotherapy of Respiratory Allergy
Dr. Bogdan Nikolov Petrunov, Professor, Laboratory of Allergy, Natiuonal Center of Infectious and Parasitic Diseases, Bulgaria

16:45-17:10

Title: Rational Vaccine Design, from Immunology to Efficacy
Dr. Olivier Cexus, Research Fellow, Agency for Science, Technology and Research (A*STAR), Singapore

 

Track 1-2: Latest Research and Technologies in Vaccines Development (II)

Time: 08:30-11:45, November 16, 2017 (Thursday); Place: Venus I, Level 3

 

Chair

Dr. Istvan Toth, Professor, University of Queensland, Australia

 

08:30-08:55

Title: Nanotechnology Based Delivery Systems for Peptides and Vaccines
Dr. Istvan Toth, Professor, University of Queensland, Australia

08:55-09:20

Title: Polymer-based Vaccine Delivery Systems
Dr. Mariusz Skwarczynski, Fellow, University of Queensland, Australia

09:20-09:45

Title: The Immunogenicity, Safety, and Consistency of an Indonesia Combined DTP-HB-Hib Vaccine in Expanded Program on Immunization Schedule
Dr. Kusnandi Rusmil, Head of Social Pediatric-Growth and Development, School of Medicine Padjadjdaran University, Indonesia

09:45-10:10

Title: The Safety and Effectiveness of Temperature-sensitive Bio-degradable Hydrogel as a Deliver System for Anti-Caries DNA Vaccine
Dr. Jianguo Liu, Professor, Zunyi Medical University, China

10:10-10:30

Coffee Break

10:30-10:55

Title: Immunization of Patients with Autoimmune Rheumatic Disease Against Influenza: A Study of Vaccine Safety and Immunogenicity
Dr. Ljudmila Stojanovich, Scientific Director, University Medical Center Bezanijska kosa, Serbia

10:55-11:20

Title: The Research of Inactivated Zika Vaccine from Vero Cell
Dr. Wang Qun, Director of R&D, Changsheng Bio-Technology Co. Ltd. China

11:20-11:45

Title: Alginate Microspheres as Delivery System and Adjuvant for Leptospiral Antigens: Preparation and Characterization
Dr. Pejvak Khak, Associate Professor and Head of Department of Microbiology, Razi Vaccine and Serum Research Institute, Iran

 

Track 2: Human Vaccines against Major Diseases

Track 2: Human Vaccines against Other Diseases  

Time:14:00-16:45, November 15, 2017 (Wednesday); Place: Venus II, Level 3

 

Chair

Dr. Elliot Parks, President and CEO, Hawaii Biotech Inc., USA

 

14:00-14:25

Title: Emerging Threats and Vaccines in Development
Dr. Elliot Parks, President and CEO, Hawaii Biotech Inc., USA

14:25-14:50

Title: Immunotherapy with PreS-based Grass Pollen Allergy Vaccine BM32 induces Antibody Responses Protecting against Hepatitis B Infection
Dr. Rainer Henning, CEO, Viravaxx GmbH, Austria

14:50-15:15

Title: Factors Connected to Hepatitis B and DTP Vaccination of Workers
Dr. Fr��d��ric J. Deschamps, Professor, IMTECA, France

15:15-15:30

Coffee Break

15:30-15:55

Title: Development Issues of HPV-vaccines and Recent Status Worldwide of HPVvaccination. Efficacy and Safety Issues Will Be Updated Also
Dr. Sven-Eric Olsson, Associate Professor, Karolinska Institute at Danderyd Hospital, Sweden

15:55-16:20

Title: Evaluation of HBV Vaccination in Egypt, Detection and Genotyping of Vaccine�� Asymptomatic Breakthrough HBV Infection
Dr. Eman A E A Abu-Shady, Professor, Microbiology Department Faculty of Medicine AL-Azhar University, Egypt

16:20-16:45

Title: Importance of Asymptomatic Humans and Dogs on the Propagation of Leishmaniasis
Dr. Cristobal Vargas, Associate Professor, CINVESTAV-IPN, Mexico

 

Track 3: Veterinary Vaccines

Track 3: Veterinary Vaccines  

Time: 08:30-11:30, November 16, 2017 (Thursday); Place: Venus II, Level 3

 

Chair

Dr. Jean-Pierre Gorvel, Research Director, INSERM, CIML, France

 

08:30-09:00

Title: New Vaccine Design Against Brucellosis
Dr. Jean-Pierre Gorvel, Research Director, INSERM, CIML, France

09:00-09:30

Title: J5 Mastitis Vaccinates' Milk Production Change and Reproductive Performance Following Clinical Mastitis Compared with Unvaccinated Dairy Cattle
Dr. David Wilson, Dairy Extension Veterinarian, Epidemiologist, Utah State University, USA

09:30-10:00

Title: Zoonoses: Human Health via Animal Health
Mr. Dmitry Lozovoy,
Director, FGBI, Russia 

10:00-10:30

Title: Developing A Protective Vaccine for Ovine Respiratory Disease
Dr. Mireia Vivas Roca, Postdoc Fellow, VIDO-InterVAC, Canada

10:30-11:00

Title: Using Vaccination against Most Dangerous Zoonotic Diseases in Russian Federation
Dr. Nikita Lebedev,
Advisor to the Head, Federal Service for Veterinary and Phytosanitary Surveillance, Russia

11:00-11:30

Title: Immunological Study of Inactivated Salmonella Enterica Serovar Typhimurium in Balb/C
Dr. Soheila Moradi Bidhendi, Associate Professor, Razi Vaccine and  Serum Research Institute, Iran

 

Track 4: Vaccines Manufacturing and Global Vaccines Market Trends

Track 4: Vaccines Manufacturing and Global Vaccines Market Trends

Time: 14:00-17:10, November 16, 2017 (Thursday); Place: Venus I, Level 3

 

Chair

Ms. Li-Jun Sim, Senior Process Engineer, Merck Pte Ltd, Singapore

 

14:00-14:25

Title: Next Generation Cell Expansion Technologies for Vaccine Production
Dr. Franco So Man Tat, Field Application Scientist, Bioprocess �C Asia, Corning Life Science, Singapore

14:25-14:50

Title: Clarification of Viral Vaccines & Vectors Using Membrane-Based Technology
Ms. Li-Jun Sim, Senior Process Engineer, Merck Pte Ltd, Singapore

14:50-15:15

Title: Potential of South East Asia �C The Hub of Vaccine Trials
Dr. Angela Chen, Associate Therapeutic Strategy Lead, Quintiles, Singapore

15:15-15:30

Coffee Break

15:30-15:55

Title: Lessons Learnt from Vaccine Trials �CPast, Present and Future
Dr. Nidhi Chlebicka, Medical Advisor, Medical Science and Strategy, Singapore

15:55-16:20

Title: Intelligent Vaccine Substrate Design �C A Whole Genome Approach
Dr. Daniel Layton, Research Scientist, Health and Biosecurity, CSIRO, Australia

16:20-16:45

Title: Reserch on the Preparation of Anti-Porphyromonas Gingivalis FimA and HagA DNA Vaccine and Its Mechanism of Action
Dr. Guohui Bai, Associate Professor, Zunyi Medical University, China

16:45-17:10

Title: Vaccines against Infectious Diseases
Dr. Ivana Balter-Haluskova, Administrative Board Member, French Society of Immunology, France

 

Track 5: Hot Topics and Innovative Technology in Immunology

Track 5: Hot Topics and Innovative Technology in Immunology  

Time: 14:00-16:30, November 16, 2017 (Thurssday); Place: Venus II, Level 3

 

Chair

Dr. James (Jianguo) Yang, CEO/President, China Division, Abpro, China

 

14:00-14:30

Title: Abpro-Innovative Antibody Drug Discovery Platform
Dr. James (Jianguo) Yang, CEO/President, China Division, Abpro, China

14:30-15:00

Title: PPAR Gamma Agonsim in Lung Immune Response
Dr. Ruxana T Sadikot, Professor of Medicine, Emory University, USA

15:00-15:30

Title: The Immunological Response of Wistar Rats with Oral Candidiasis
Dr. Basma Ezzat Mustafa, Assistant Professor, International Islamic University, Malaysia

15:30-16:00

Title: Identification of Genes Involved in Skin Immunity by Epidermal Immunophenotyping with Automated Image Analysis
Dr. Dmitry Ushakov,
Research Associate, King's College London, UK

16:00-16:30

Title: Understanding Lipid Peroxidation and Aberrant Lipid Metabolism in Ocular Cancer: Pivotal Role of Immunoassays
Dr. P. R. Deepa, Associate Professor, Birla Institute of Technology & Science (BITS), Pilani, India

 

Track 6: Clinical Immunology

Track 6: Clinical Immunology  

Time: 08:30-11:00, November 17, 2017 (Friday); Place: Venus I, Level 3

 

Chair

Dr. Oliver Bohnsack, Senior Director, PAREXEL, German

 

08:30-09:00

Title: The Evolution of Imaging and Its Criteria in Oncology Clinical Trials
Dr. Oliver Bohnsack, Senior Director, PAREXEL, Germany

09:00-09:30

Title: The Value a New Molecular Technique in the Diagnosis of Pneumocystis Jirovecii Pneumonia (PJP) in Renal Transplant Patients in Kuwait
Dr. Eiman Mohamed Mokaddas, Professor, Kuwait University, Kuwait

09:30-10:00

Title: Antibody Associated Virus to Potential Epitopes: A Reverse Epitope Mapping Strategy
Dr. Liam J. Fanning, Senior Lecturer, University College Cork, Ireland

10:00-10:30

Title: Prospects for Gene Therapy to Treat Diabetes in the Context of An Historical Summary of the Landmarks in Diabetes Research
Dr. Roy Calne,
Professor, University of Cambridge, UK

10:30-11:00

Title: A 3-D Microfluidic Model for Preclinical Evaluation of TCR-Engineered T Cells aainst Solid Tumors
Dr. Andrea Pavesi, Junior Investigator, Institute of Molecular and Cell Biology (IMCB), Singapore

News Updates
Hosting Organization
Supporting Organizations
Official Travel Agency
BIT's Upcoming Events
©2016-2017 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609-801-801, : 0086-411-84799609-801